Welcome to our dedicated page for Fuller H B news (Ticker: FUL), a resource for investors and traders seeking the latest updates and insights on Fuller H B stock.
H.B. Fuller Company reports developments in its global adhesives, sealants and functional coatings business under NYSE symbol FUL. News commonly covers quarterly and annual results, gross margin trends, pricing and raw-material cost actions, dividends on common stock, and portfolio or footprint initiatives tied to Project Quantum Leap.
The company serves packaging, converting, hygiene, health and beauty, construction, engineering and aerospace-related applications through specialty industrial adhesive technologies. Updates also include manufacturing investments, supply-continuity actions, and customer support for regulated markets such as aviation, space and defense.
H.B. Fuller (NYSE: FUL) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.2450 per share on its common stock. The dividend is payable on August 13, 2026 to shareholders of record as of the close of business on July 30, 2026. H.B. Fuller reports it has paid quarterly cash dividends for 58 consecutive years.
MITER Brands announced the launch of its new Triton Advanced Glass Systems, developed in strategic collaboration with Corning and leveraging H.B. Fuller 4SG Fusion Bonded Spacer technology. The line is designed to improve installation ease, comfort, energy efficiency, noise reduction, and storm protection for residential windows and doors.
The Triton portfolio initially includes Triton Advanced Impact and Triton Advanced Triple Pane, both featuring micro-thin Corning Enlighten Glass. Triton Advanced Impact targets coastal and Florida homeowners and will replace the current Diamond Glass name, while Triton Advanced Triple Pane will be offered in the Sunrise Collection replacement products.
Summary not available.
H.B. Fuller (NYSE:FUL) announced a recommended all-cash offer to acquire Advanced Medical Solutions Group for £2.85 per share, implying enterprise value of £715 million.
The deal adds about $300 million in revenue, lifts TAM by $15 billion to $95 billion, targets ~$55 million run-rate synergies by 2031, and supports a path to >20% EBITDA margins. It will be fully debt-financed with plans to deleverage to 2.5x–3x within two years, and is expected to close by year-end, subject to shareholder and regulatory approvals.
H.B. Fuller (NYSE: FUL) reported second quarter 2026 net revenue of $950 million, up 5.8% year-on-year, with organic revenue up 2.6%. Adjusted EBITDA rose 9% to $181 million and adjusted EPS (diluted) increased 19% to $1.41. Operating cash flow reached a record $121 million.
Net income was $68 million; adjusted gross margin improved 200 basis points to 34.2%. Net debt fell to $1,958 million, and net debt-to-adjusted EBITDA improved to 3.1x. The company raised the midpoint of full-year 2026 adjusted EBITDA and adjusted EPS guidance.
H.B. Fuller (NYSE: FUL) released its 2025 Sustainability Report, setting new 2030 environmental targets and outlining progress integrating sustainability into strategy, innovation, and operations.
Goals include cuts to Scope 1 and 2 emissions, water demand, waste intensity, higher recycling rates, and growing sustainable product innovation.
Summary not available.
H.B. Fuller (NYSE: FUL) announced a strategic investment in VerdaFresh, an advanced oxygen barrier coating that strengthens its sustainable packaging portfolio.
The proprietary, recycler-friendly technology enables mono-material, fully recyclable packaging structures, removes the need for EVOH and other hard-to-recycle layers, and aims to cut waste, materials use, and carbon impact while maintaining product shelf life.
H.B. Fuller (NYSE: FUL) outlined its value creation and M&A strategy. The company targets adjusted EBITDA margins >20%, low-teens ROIC and strong cash flow conversion as it pivots toward higher-margin specialty adhesives.
Since early 2023, H.B. Fuller has executed 13 acquisitions. In the U.K., four deals since 2022 expanded acquired adjusted EBITDA from $30 million at ~13% margin to over $60 million at >23% margin in three years. Net debt to adjusted EBITDA fell to 3.1x at Q1-end from 3.5x a year earlier. The company is in discussions regarding Advanced Medical Solutions Group but notes there is no certainty a binding offer will be made.
Ancora Holdings Group, owning over 2% of H.B. Fuller (NYSE: FUL), released a letter opposing H.B. Fuller’s attempt to acquire U.K.-based Advanced Medical Solutions (AMS). Ancora argues the transaction would raise leverage above 4.0x Net Debt / Proforma Adjusted EBITDA, worsen the company’s valuation multiple and contradict prior deleveraging commitments.
Ancora urges the board to abandon the AMS pursuit and instead initiate a full review of strategic alternatives, including potential sale options, citing H.B. Fuller’s trading discount and what it believes is meaningful acquirer interest.